Is the prevalence of NAFLD higher in women and girls with PCOS compared to those without PCOS?
Women with PCOS have a significantly higher worldwide prevalence of NAFLD compared to women without PCOS, emphasizing the importance of metabolic screening in this population.
Here, we review NAFLD in women with PCOS with subsections focused on the impact of hyperandrogenism, BMI, insulin resistance and age. Most notably, we present the most up-to-date racially and ethnically diverse worldwide prevalence of NAFLD in women with PCOS compared with women without PCOS (51.56% vs 29.64%, P < .001, respectively).
Falzarano et al. (Tue,) studied this question.